In Situ Simulation Training in Transferring Critically Ill COVID-19 Patients

Sponsor
Indonesia University (Other)
Overall Status
Completed
CT.gov ID
NCT05113823
Collaborator
(none)
40
1
2
3.9
10.2

Study Details

Study Description

Brief Summary

This study aimed to determine the role of in situ simulation training during a pandemic by using standard and high-fidelity mannequins to improve interprofessional communication, skills, and teamwork in transferring critically ill COVID-19 patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Simulation Training
N/A

Detailed Description

Fourty subjects were randomly allocated into two large groups, the High Fidelity Simulator group and the Low Fidelity Simulator group. Each group was divided into small groups, consist of 2 doctors and 3 nurses. All subjects underwent the same interactive lectures, and two sessions of in-situ simulation according to their assign group. In-situ simulation and debriefing were performed by implementing appropriate personal protective equipment and social distancing. At the end of each simulation session, each group would underwent a debriefing session, which was performed by an experience instructor. The first simulation was aimed to teach participants skills and steps in transporting critically-ill COVID-19 patients according to the hospital check-list. While the second simulation was aimed to assess skills, team work and communication that participants had learned from the previous simulation, by using assessment tools that had been developed before. In addition to comparing each point in the assessment tool between the two groups, the points that had been earned were also added up to get the overall points for total skills, cooperation and communication score. At the end of the session, learner immediate feedback were also collected using an online feedback form, which provided accountability for attendance, content learning, and course evaluation feedback.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Health Services Research
Official Title:
In Situ Simulation Training for a Better Interprofessional Team Performance in Transferring Critically Ill COVID-19 Patients: A Prospective Randomized Control Trial
Actual Study Start Date :
Nov 16, 2020
Actual Primary Completion Date :
Nov 19, 2020
Actual Study Completion Date :
Mar 15, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: High Fidelity Simulator

Subjects will receive training using high fidelity simulator

Procedure: Simulation Training
Simulation Training using High and Low Fidelity Simulator

Active Comparator: Low Fidelity Simulator

Subjects will receive training using low fidelity simulator

Procedure: Simulation Training
Simulation Training using High and Low Fidelity Simulator

Outcome Measures

Primary Outcome Measures

  1. rate of interprofessional communication [within 3 months]

    improvement of interprofessional communication in transferring critically ill COVID-19 patients

  2. rate of skill [within 3 months]

    improvement of skill in transferring critically ill COVID-19 patients

  3. rate of team work [within 3 months]

    improvement of team work in transferring critically ill COVID-19 patients

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • in good physical condition

  • had no history of involving in COVID-19 patients care

  • willing to become study subject

Exclusion Criteria:
  • doesn't want to become study subject

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cipto Mangunkusumo Cental National Hospital Jakarta DKI Jakarta Indonesia 10430

Sponsors and Collaborators

  • Indonesia University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aida Rosita Tantri, Doctor, Indonesia University
ClinicalTrials.gov Identifier:
NCT05113823
Other Study ID Numbers:
  • IndonesiaUAnes122
First Posted:
Nov 9, 2021
Last Update Posted:
Nov 9, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aida Rosita Tantri, Doctor, Indonesia University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 9, 2021